A Quantitative Assay for Epstein-Barr Virus–Specific Immunity Shows Interferon-γ Producing CD8+ T Cells Increase During Immunosuppression Reduction to Treat Posttransplant Lymphoproliferative Disease-Reference-Cited by-同舟云学术

A Quantitative Assay for Epstein-Barr Virus–Specific Immunity Shows Interferon-γ Producing CD8+ T Cells Increase During Immunosuppression Reduction to Treat Posttransplant Lymphoproliferative Disease

Published:2007-12-15 Issue:11 Volume:84 Page:1534-1539
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Guppy Amy E.,Rawlings Eira,Madrigal J Alejandro,Amlot Peter L.,Barber Linda D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference18 articles.

1. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.;Rickinson;Annu Rev Immunol,1997

2. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.;Rooney;Lancet,1995

3. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.;Khanna;Proc Natl Acad Sci U S A,1999

4. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.;Haque;Lancet,2002

5. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).;Savoldo;Blood,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. αβ and γδ T-cell responses to Epstein-Barr Virus: insights in immunocompetence, immune failure and therapeutic augmentation in transplant patients;Current Opinion in Immunology;2023-06

2. In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder;Kidney International;2022-12

3. Management of PTLD after SOT;Post-Transplant Lymphoproliferative Disorders;2021

4. Recent advances in understanding and managing infectious diseases in solid organ transplant recipients;F1000Research;2018-05-24

5. Cancer and mTOR Inhibitors in Transplant Recipients;Transplantation;2017-01